Advertisement

Chimp Patents Challenged

Three patents on transgenic apes in the European Union will be challenged by animal rights activists.

By | November 16, 2012

Chimpanzee at the Singapore ZooFlickr, Chi KingA German advocacy group called No Patents on Life has filed one challenge against a patent for genetically engineered chimpanzees and plans to file two more, according to a spokesperson for the group.

"It is incomprehensible why the patent office would grant patents on these animals," Ruth Tipp, a spokesperson for the group told ScienceInsider. Although research on our closest relatives has become relatively rare, compared to research on other animal models, Tipp worries that such a patent would create an easier path to using the animals.

The company that owns the patent, Intrexon of Blacksburg, Virginia, said that 99 percent of the content of the patent is not related to chimpanzees.  Rather, the company has invented a way to turn genes on or off in rats, rabbits, horses, and other animals, including chimps.

Intrexon will have 6 months to prepare its defense, after which time the patent may be left unchanged, revoked, or amended.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Ed M.

Ed M.

Posts: 45

November 18, 2012

Can I patent myself?

 

I am a unique genetic sui generis combo.

Advertisement
BD Bioscience
BD Bioscience

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Amyloid Thwarts Microbial Invaders
    Daily News Amyloid Thwarts Microbial Invaders

    Alzheimer’s disease–associated amyloid-β peptides trap microbes in the brains of mice and in the guts of nematodes, a study shows. 

Advertisement
R&D Systems
R&D Systems
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate